Gastroparesis cured by gastrectomy.

PubWeight™: 1.41‹?› | Rank: Top 5%

🔗 View Article (PMID 10372257)

Published in Diabetes Care on June 01, 1999

Authors

D S Bell, F Ovalle

Articles by these authors

Toward a medical-concept representation language. The Canon Group. J Am Med Inform Assoc (1995) 13.91

Myalgic encephalomyelitis: International Consensus Criteria. J Intern Med (2011) 4.98

Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease. Science (1987) 3.23

"Repetition strain injury": an iatrogenic epidemic of simulated injury. Med J Aust (1989) 1.84

Structured entry of radiology reports using World Wide Web technology. Radiographics (1996) 1.54

Retroviral sequences related to human T-lymphotropic virus type II in patients with chronic fatigue immune dysfunction syndrome. Proc Natl Acad Sci U S A (1991) 1.51

Ethics in diabetic clinical trials. Diabetes Care (2001) 1.45

Troglitazone's effect on lipoprotein(a) levels. Diabetes Care (1999) 1.43

How long can insulin therapy be avoided in the patient with type 2 diabetes mellitus by use of a combination of metformin and a sulfonylurea? Endocr Pract (2001) 1.41

The roles of orthostatic hypotension, orthostatic tachycardia, and subnormal erythrocyte volume in the pathogenesis of the chronic fatigue syndrome. Am J Med Sci (2000) 1.22

The experimental reproduction of amphetamine psychosis. Arch Gen Psychiatry (1973) 1.21

Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes. Diabetes (1998) 1.11

Dangers of treatment of status epilepticus with diazepam. Br Med J (1969) 1.09

Cardiovascular disease in South Asians. Lancet (2000) 1.06

A nomothetic-idiographic study of daily psychological stress and blood glucose in women with type I diabetes mellitus. J Behav Med (1994) 1.04

Stereotactic amygdaloidotomy for aggressive behaviour. J Neurol Neurosurg Psychiatry (1974) 1.04

Psychiatric aspects of cerebral vascular disease. Med J Aust (1966) 1.04

Speech functions of the thalamus inferred from the effects of thalamotomy. Brain (1968) 1.02

Addiction to stimulants. Med J Aust (1967) 1.00

Use of soy protein supplement and resultant need for increased dose of levothyroxine. Endocr Pract (2001) 0.99

Absence of antibody to Mycoplasma fermentans in patients with chronic fatigue syndrome. Clin Infect Dis (1993) 0.94

Complications of diabetes. Prevalence, detection, current treatment, and prognosis. Am J Med (1985) 0.93

Risk factors associated with chronic fatigue syndrome in a cluster of pediatric cases. Rev Infect Dis (1991) 0.93

Oral candidiasis in patients with diabetes mellitus: a thorough analysis. Diabetes Care (1988) 0.90

Contributing factors identified by hospital incident report narratives. Qual Saf Health Care (2008) 0.90

Daily stress variability, learned resourcefulness, regimen adherence, and metabolic control in type I diabetes mellitus: evaluation of a path model. J Consult Clin Psychol (1992) 0.89

Interleukin-2 and the chronic fatigue syndrome. Ann Intern Med (1989) 0.87

Improved glycemic control with use of continuous subcutaneous insulin infusion compared with multiple insulin injection therapy. Endocr Pract (2001) 0.85

Glucokinase gene in gestational diabetes mellitus: population association study and molecular scanning. Diabetologia (1994) 0.84

Automated quantification of color Doppler signals: a preliminary study in breast tumors. Radiology (1995) 0.83

Hypoglycemia induced by enalapril in patient with insulin resistance and NIDDM. Diabetes Care (1992) 0.82

An evaluation of patient performance of and their satisfaction with various rapid blood glucose measurement systems. Diabetes Care (1983) 0.82

Hyperleptinemia in patients with end-stage renal disease undergoing continuous ambulatory peritoneal dialysis. Perit Dial Int (1998) 0.81

Prevalence and risk factors of microalbuminuria in a cohort of African-American women with gestational diabetes. Diabetes Care (2001) 0.81

Variability of the pancreatic islet beta cell/liver (GLUT 2) glucose transporter gene in NIDDM patients. Diabetologia (1994) 0.80

The effect of diazepam on the EEG of status epilepticus. J Neurol Neurosurg Psychiatry (1970) 0.79

Combination therapy for type 2 diabetes. Am Fam Physician (2001) 0.79

Neurosurgical disease encountered in a psychiatric service. J Neurol Neurosurg Psychiatry (1974) 0.79

Evaluation of soft-tissue masses using segmented color Doppler velocity images: preliminary observations. AJR Am J Roentgenol (1999) 0.78

Long-term glycaemic efficacy and weight changes associated with thiazolidinediones when added at an advanced stage of type 2 diabetes. Diabetes Obes Metab (2006) 0.78

Screening for slight albuminuria: a comparison of selected commercially available methods. South Med J (1990) 0.78

HLA-A, -B, and -DR associations in type I diabetes mellitus with onset after age forty. Diabetes (1982) 0.78

HFE mutations in African-American women with non-insulin-dependent diabetes mellitus. Ethn Dis (2001) 0.78

Metformin lowers lipoprotein(a) levels. Diabetes Care (1998) 0.77

Diagnostic, pathogenetic, and therapeutic aspects of diabetic neuropathy. Spec Top Endocrinol Metab (1982) 0.77

Late-onset troglitazone-induced hepatic dysfunction. Diabetes Care (2000) 0.77

Outcomes of initiation of therapy with once-daily combination of a thiazolidinedione and a biguanide at an early stage of type 2 diabetes. Diabetes Obes Metab (2004) 0.77

Genes within and flanking the major histocompatibility region are risk factors for diabetes, insulin resistance, hypertension, and microalbuminuria in African-American women. Transplant Proc (1997) 0.77

Tissue triglyceride levels in type 2 diabetes and the role of thiazolidinediones in reversing the effects of tissue hypertriglyceridemia: review of the evidence in animals and humans. Endocr Pract (2001) 0.77

Increased prevalence of mitral valve prolapse in IDDM. Diabetes Care (1996) 0.76

Triple oral antidiabetic therapy in type 2 diabetes mellitus. Endocr Pract (2004) 0.76

Effect of insulin therapy on lipoproteins in non-insulin dependent diabetes mellitus (NIDDM). Atherosclerosis (1987) 0.76

Serum angiotensin-converting enzyme as a marker for the chronic fatigue-immune dysfunction syndrome: a comparison to serum angiotensin-converting enzyme in sarcoidosis. Am J Med (1993) 0.75

Sulfonylurea failure in non-insulin-dependent diabetes mellitus. Am J Med (1990) 0.75

Sequelae to pneumoencephalography. J Neurol Neurosurg Psychiatry (1973) 0.75

Hormone replacement therapy and serum uric acid. Lancet (1999) 0.75

Hypoglycemia in children with insulin-dependent diabetes mellitus. J Pediatr (1990) 0.75

Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. N Engl J Med (2000) 0.75

Decrease in mortality from diabetic nephropathy in Pima Indians. Diabetes Care (1996) 0.75

A retrospective analysis of interruptive versus non-interruptive clinical decision support for identification of patients needing contact isolation. Appl Clin Inform (2013) 0.75

Taking chronic fatigue syndrome seriously. Am J Psychiatry (1992) 0.75

Long- and short-term blood pressure and RR-interval variability and psychosomatic distress in chronic fatigue syndrome. Clin Sci (Lond) (1999) 0.75

Double-blind trial of anorectic agents. Med J Aust (1969) 0.75

Colour DOPPLER image analysis for tissue vascularity and perfusion: a preliminary clinical evaluation. Ultrasound Med Biol (1995) 0.75

The effects of methylamphetamine on stereotyped behaviour, activity, startle, and orienting responses. Psychopharmacologia (1972) 0.75

Immunotherapy of insulin-dependent diabetes. Ala J Med Sci (1985) 0.75

Back to fundamentalism. Drug Alcohol Depend (1983) 0.75

Cryogenic thalamotomy in Parkinson's disease. Med J Aust (1967) 0.75

Plan for a drug-dependence service for New South Wales. I. Background. Med J Aust (1971) 0.75

Effect of vitamin C on lamb pneumonia and mortality. Cornell Vet (1967) 0.75

Reversal of the carpal tunnel syndrome after change of insulin injection sites. Diabetes Care (1983) 0.75

The precipitants of amphetamine addiction. Br J Psychiatry (1971) 0.75

Diagnosis of panic disorder. Med J Aust (1984) 0.75

Tolerance to the hyperactivating effects of methylamphetamine. Psychopharmacologia (1974) 0.75

Conversion from troglitazone to rosiglitazone. Endocr Pract (2001) 0.75

Low incidence of false-positive exercise thallium 201 scintigraphy in a diabetic population. Diabetes Care (1996) 0.75

Plan for a drug-dependence service for New South Wales. II. Management of the problem. Med J Aust (1971) 0.75

[Infusion of simple insulin in low doses in the management of diabetic ketoacidosis. Experience with 140 cases]. Rev Invest Clin (1982) 0.75

C-Peptide utilization in clinical practice: effect on treatment and outcome of diabetes in a series of cases. Endocr Pract (2004) 0.75

Status epilepticus and diazepam. Br Med J (1969) 0.75

Genes within the major histocompatibility complex predict NIDDM in African-American women in Alabama. Diabetes Care (1994) 0.75

Troglitazone interferes with gemfibrozil's lipid-lowering action. Diabetes Care (1998) 0.75

Rapid insulin initiation in non-insulin-dependent diabetes mellitus. Am J Med (1987) 0.75

Approximate determination of the speed of sound through liquids and solids. J Acoust Soc Am (1968) 0.75

Adaptive speckle reduction for improving the differential diagnosis of breast lesions. J Ultrasound Med (1995) 0.75

Epilepsy in childhood. Med J Aust (1972) 0.75

National campaign against drug abuse. Med J Aust (1986) 0.75

Transference in a group with different therapists. Aust N Z J Psychiatry (1972) 0.75

Treatment of epilepsy. Med J Aust (1984) 0.75

Influence of a penicillin-streptomycin preparation on lamb mortality. J Am Vet Med Assoc (1967) 0.75

Acuphobia in a long-standing insulin-dependent diabetic patient cured by hypnosis. Diabetes Care (1984) 0.75

[Study Group for Thyroid Cancer in Mexico (CATIMEX). Collaborative study of 194 cases]. Rev Invest Clin (1983) 0.75

The motivation of addiction. Acta Neurochir (Wien) (1995) 0.75

Postprandial rather than preprandial glucose levels should be used for adjustment of rapid-acting insulins. Endocr Pract (2001) 0.75